IL122215A - Dolastatin derivatives as antineoplastics and their preparation - Google Patents

Dolastatin derivatives as antineoplastics and their preparation

Info

Publication number: IL122215A
Authority: IL; Israel
Prior art keywords: antineoplastics; preparation; dolastatin derivatives; dolastatin; derivatives
Prior art date: 1995-06-07

Application number

IL12221596A

Other languages

English (en)

Other versions

IL122215A0 (en

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-06-03

Publication date

2001-08-26

1996-06-03 Application filed by Basf Ag filed Critical Basf Ag

1998-04-05 Publication of IL122215A0 publication Critical patent/IL122215A0/xx

2001-08-26 Publication of IL122215A publication Critical patent/IL122215A/xx

Links

230000000118 anti-neoplastic effect Effects 0.000 title 1
229940034982 antineoplastic agent Drugs 0.000 title 1
239000002246 antineoplastic agent Substances 0.000 title 1
AMRJKAQTDDKMCE-UHFFFAOYSA-N dolastatin Chemical class CC(C)C(N(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(C(C)C)C(OC)CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C=1SC=CN=1)CC1=CC=CC=C1 AMRJKAQTDDKMCE-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IL12221596A 1995-06-07 1996-06-03 Dolastatin derivatives as antineoplastics and their preparation IL122215A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/472,453 US5831002A (en)	1992-05-20	1995-06-07	Antitumor peptides
PCT/EP1996/002392 WO1996040751A1 (en)	1995-06-07	1996-06-03	Novel dolastatin derivatives, their preparation and use

Publications (2)

Publication Number	Publication Date
IL122215A0 IL122215A0 (en)	1998-04-05
IL122215A true IL122215A (en)	2001-08-26

Family

ID=23875567

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12221596A IL122215A (en)	1995-06-07	1996-06-03	Dolastatin derivatives as antineoplastics and their preparation
IL12221696A IL122216A (en)	1995-06-07	1996-06-03	Dolastatin derivatives as antineoplastics and their preparation

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL12221696A IL122216A (en)	1995-06-07	1996-06-03	Dolastatin derivatives as antineoplastics and their preparation

Country Status (33)

Country	Link
US (1)	US5831002A (cs)
EP (2)	EP0832104B1 (cs)
JP (2)	JP4221062B2 (cs)
KR (2)	KR100437986B1 (cs)
CN (2)	CN1182153C (cs)
AR (2)	AR003427A1 (cs)
AT (2)	ATE224910T1 (cs)
AU (2)	AU725164B2 (cs)
BG (2)	BG102125A (cs)
BR (2)	BR9609424A (cs)
CA (2)	CA2219818C (cs)
CO (2)	CO4700527A1 (cs)
CZ (2)	CZ293682B6 (cs)
DE (2)	DE69623992T2 (cs)
DK (2)	DK0832104T3 (cs)
ES (2)	ES2188759T3 (cs)
HR (2)	HRP960277A2 (cs)
HU (2)	HU228071B1 (cs)
IL (2)	IL122215A (cs)
MX (2)	MX9709147A (cs)
MY (2)	MY119042A (cs)
NO (2)	NO318384B1 (cs)
NZ (2)	NZ310444A (cs)
PL (2)	PL185763B1 (cs)
PT (2)	PT871656E (cs)
RO (2)	RO119783B1 (cs)
SI (2)	SI0832104T1 (cs)
SK (1)	SK282466B6 (cs)
TR (2)	TR199701544T1 (cs)
TW (2)	TW508357B (cs)
UA (2)	UA46775C2 (cs)
WO (2)	WO1996040752A1 (cs)
ZA (2)	ZA964710B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5807984A (en) *	1995-11-09	1998-09-15	Basf Aktienegesellschaft	Oligopeptides, the preparation and use thereof
TW474946B (en) *	1995-12-15	2002-02-01	Basf Ag	Novel compounds, the preparation and use thereof
US20010009901A1 (en) *	1996-12-11	2001-07-26	Basf Aktiengesellschaft Germany	Antineoplastic peptides
US5965537A (en) *	1997-03-10	1999-10-12	Basf Aktiengesellschaft	Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) *	1997-03-13	2000-08-15	Basf Aktiengesellschaft	Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) *	1997-07-18	2000-11-07	Basf Aktiengesellschaft	Dolastatin 15 derivatives
US6015790A (en) *	1997-10-06	2000-01-18	Basf Aktiengesellschaft	Methods and compositions for treating rheumatoid arthritis
US5985837A (en) *	1998-07-08	1999-11-16	Basf Aktiengesellschaft	Dolastatin 15 derivatives
EP1159273A1 (en)	1999-03-02	2001-12-05	Boehringer Ingelheim Pharmaceuticals Inc.	Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en)	1999-09-13	2002-07-16	Boehringer Ingelheim Pharmaceuticals, Inc.	Compound useful as reversible inhibitors of cysteine proteases
AU775373B2 (en)	1999-10-01	2004-07-29	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US7018642B2 (en)	2001-04-27	2006-03-28	The Procter & Gamble Company	Compounds, compositions, and methods for controlling biofilms
WO2003051835A2 (en) *	2001-12-18	2003-06-26	Proteologics, Inc.	Methods and compositions for the inhibition of viral release
EP1531846A4 (en) *	2002-02-27	2006-04-19	Us Gov Health & Human Serv	Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
EP1781310B1 (en)	2004-08-02	2015-10-14	Ramot at Tel Aviv University Ltd.	Articles of peptide nanostructures and method of forming the same
JP4954983B2 (ja)	2005-05-18	2012-06-20	ファーマサイエンス・インコーポレイテッド	Ｂｉｒドメイン結合化合物
AU2006283677A1 (en) *	2005-08-19	2007-03-01	Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Topical formulations of histone deacetylase inhibitors and methods of using the same
EP1973928A2 (en) *	2005-10-11	2008-10-01	Ramot at Tel-Aviv University Ltd.	Self-assembled fmoc-ff hydrogels
CN101535300B (zh)	2006-05-16	2014-05-28	埃格拉医疗公司	Iap bir域结合化合物
JP5452223B2 (ja) *	2006-07-24	2014-03-26	テトラロジックファーマシューティカルズコーポレーション	Ｉａｐ阻害剤
WO2008127560A1 (en) *	2007-04-12	2008-10-23	Scinopharm Taiwan Ltd.	Process for making galantamine
UY32099A (es)	2008-09-11	2010-04-30	Enanta Pharm Inc	Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8283372B2 (en)	2009-07-02	2012-10-09	Tetralogic Pharmaceuticals Corp.	2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
US9284350B2 (en)	2010-02-12	2016-03-15	Pharmascience Inc.	IAP BIR domain binding compounds
CA2822556A1 (en)	2010-12-30	2012-07-05	Enanta Pharmaceuticals, Inc	Macrocyclic hepatitis c serine protease inhibitors
EA201390988A1 (ru)	2010-12-30	2014-04-30	Энанта Фармасьютикалз, Инк.	Фенантридиновые макроциклические ингибиторы сериновой протеазы вируса гепатита c
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
KR102356286B1 (ko)	2011-05-27	2022-02-08	암브룩스, 인코포레이티드	비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
WO2015103490A1 (en)	2014-01-03	2015-07-09	Abbvie, Inc.	Solid antiviral dosage forms
CN118119409A (zh)	2021-09-03	2024-05-31	东丽株式会社	癌的治疗和/或预防用药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816444A (en) *	1987-07-10	1989-03-28	Arizona Board Of Regents, Arizona State University	Cell growth inhibitory substance
US4879278A (en) *	1989-05-16	1989-11-07	Arizona Board Of Regents	Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
WO1993003054A1 (fr) *	1991-08-09	1993-02-18	Teikoku Hormone Mfg. Co., Ltd.	Nouveau derive de tetrapeptide
CA2136339C (en) *	1992-05-20	2008-02-05	Andreas Haupt	Derivatives of dolastatin
US5530097A (en) *	1994-08-01	1996-06-25	Arizona Board Of Regents Acting On Behalf Of Arizona State University	Human cancer inhibitory peptide amides
US5504191A (en) *	1994-08-01	1996-04-02	Arizona Board Of Regents Acting On Behalf Of Arizona State University	Human cancer inhibitory pentapeptide methyl esters

1995
- 1995-06-07 US US08/472,453 patent/US5831002A/en not_active Expired - Lifetime
1996
- 1996-06-03 DE DE69623992T patent/DE69623992T2/de not_active Expired - Lifetime
- 1996-06-03 ES ES96918661T patent/ES2188759T3/es not_active Expired - Lifetime
- 1996-06-03 WO PCT/EP1996/002393 patent/WO1996040752A1/en not_active Ceased
- 1996-06-03 RO RO97-02254A patent/RO119783B1/ro unknown
- 1996-06-03 IL IL12221596A patent/IL122215A/xx not_active IP Right Cessation
- 1996-06-03 MY MYPI96002155A patent/MY119042A/en unknown
- 1996-06-03 WO PCT/EP1996/002392 patent/WO1996040751A1/en not_active Ceased
- 1996-06-03 RO RO97-02264A patent/RO118953B1/ro unknown
- 1996-06-03 AU AU61241/96A patent/AU725164B2/en not_active Ceased
- 1996-06-03 PL PL96323726A patent/PL185763B1/pl unknown
- 1996-06-03 CN CNB961944684A patent/CN1182153C/zh not_active Expired - Fee Related
- 1996-06-03 JP JP50013297A patent/JP4221062B2/ja not_active Expired - Fee Related
- 1996-06-03 TR TR97/01544T patent/TR199701544T1/xx unknown
- 1996-06-03 BR BR9609424-9A patent/BR9609424A/pt not_active Application Discontinuation
- 1996-06-03 NZ NZ310444A patent/NZ310444A/xx not_active IP Right Cessation
- 1996-06-03 UA UA98010069A patent/UA46775C2/uk unknown
- 1996-06-03 SI SI9630539T patent/SI0832104T1/xx unknown
- 1996-06-03 HU HU9801910A patent/HU228071B1/hu not_active IP Right Cessation
- 1996-06-03 CZ CZ19973763A patent/CZ293682B6/cs not_active IP Right Cessation
- 1996-06-03 HU HU9801817A patent/HU228073B1/hu not_active IP Right Cessation
- 1996-06-03 PL PL96323723A patent/PL185762B1/pl unknown
- 1996-06-03 DK DK96918660T patent/DK0832104T3/da active
- 1996-06-03 SI SI9630550T patent/SI0871656T1/xx unknown
- 1996-06-03 NZ NZ310443A patent/NZ310443A/en not_active IP Right Cessation
- 1996-06-03 CA CA002219818A patent/CA2219818C/en not_active Expired - Fee Related
- 1996-06-03 MX MX9709147A patent/MX9709147A/es unknown
- 1996-06-03 UA UA98010070A patent/UA46776C2/uk unknown
- 1996-06-03 CN CNB961944676A patent/CN1182154C/zh not_active Expired - Fee Related
- 1996-06-03 KR KR1019970709064A patent/KR100437986B1/ko not_active Expired - Fee Related
- 1996-06-03 TR TR97/01545T patent/TR199701545T1/xx unknown
- 1996-06-03 KR KR1019970709063A patent/KR100437985B1/ko not_active Expired - Fee Related
- 1996-06-03 CA CA002219819A patent/CA2219819C/en not_active Expired - Fee Related
- 1996-06-03 PT PT96918661T patent/PT871656E/pt unknown
- 1996-06-03 AT AT96918661T patent/ATE224910T1/de active
- 1996-06-03 PT PT96918660T patent/PT832104E/pt unknown
- 1996-06-03 CZ CZ19973765A patent/CZ293683B6/cs not_active IP Right Cessation
- 1996-06-03 BR BR9609423A patent/BR9609423A/pt not_active Application Discontinuation
- 1996-06-03 EP EP96918660A patent/EP0832104B1/en not_active Expired - Lifetime
- 1996-06-03 ES ES96918660T patent/ES2186783T3/es not_active Expired - Lifetime
- 1996-06-03 SK SK1653-97A patent/SK282466B6/sk not_active IP Right Cessation
- 1996-06-03 IL IL12221696A patent/IL122216A/en not_active IP Right Cessation
- 1996-06-03 MX MX9709146A patent/MX9709146A/es unknown
- 1996-06-03 DE DE69623472T patent/DE69623472T2/de not_active Expired - Lifetime
- 1996-06-03 DK DK96918661T patent/DK0871656T3/da active
- 1996-06-03 JP JP50013197A patent/JP3957751B2/ja not_active Expired - Fee Related
- 1996-06-03 EP EP96918661A patent/EP0871656B1/en not_active Expired - Lifetime
- 1996-06-03 AU AU61242/96A patent/AU725170B2/en not_active Ceased
- 1996-06-03 AT AT96918660T patent/ATE223431T1/de active
- 1996-06-04 MY MYPI96002170A patent/MY124487A/en unknown
- 1996-06-06 ZA ZA9604710A patent/ZA964710B/xx unknown
- 1996-06-06 AR ARP960102981A patent/AR003427A1/es active IP Right Grant
- 1996-06-06 AR ARP960102980A patent/AR003136A1/es active IP Right Grant
- 1996-06-06 ZA ZA9604711A patent/ZA964711B/xx unknown
- 1996-06-06 HR HR08/472,453A patent/HRP960277A2/hr not_active Application Discontinuation
- 1996-06-06 HR HR08/472,453A patent/HRP960257A2/hr not_active Application Discontinuation
- 1996-06-07 CO CO96029751A patent/CO4700527A1/es unknown
- 1996-06-07 CO CO96029749A patent/CO4700526A1/es unknown
- 1996-06-07 TW TW085106866A patent/TW508357B/zh not_active IP Right Cessation
- 1996-10-02 TW TW085106867A patent/TW424096B/zh not_active IP Right Cessation
1997
- 1997-12-05 NO NO19975710A patent/NO318384B1/no not_active IP Right Cessation
- 1997-12-05 NO NO19975711A patent/NO317670B1/no not_active IP Right Cessation
- 1997-12-18 BG BG102125A patent/BG102125A/xx unknown
- 1997-12-29 BG BG102152A patent/BG102152A/xx unknown

Also Published As

Publication number	Publication date
CZ293682B6 (cs)	2004-07-14
DE69623472D1 (de)	2002-10-10
IL122216A0 (en)	1998-04-05
HUP9801910A3 (en)	1999-06-28
JPH11504652A (ja)	1999-04-27
PL185763B1 (pl)	2003-07-31
WO1996040752A1 (en)	1996-12-19
HU228073B1 (hu)	2012-09-28
JPH11504653A (ja)	1999-04-27
DK0871656T3 (da)	2003-01-27
PT871656E (pt)	2002-12-31
JP4221062B2 (ja)	2009-02-12
ATE223431T1 (de)	2002-09-15
US5831002A (en)	1998-11-03
NO318384B1 (no)	2005-03-14
CN1182154C (zh)	2004-12-29
WO1996040751A1 (en)	1996-12-19
ES2188759T3 (es)	2003-07-01
ES2186783T3 (es)	2003-05-16
PT832104E (pt)	2002-12-31
CN1187198A (zh)	1998-07-08
CN1187199A (zh)	1998-07-08
KR100437985B1 (ko)	2004-09-18
MX9709147A (es)	1998-03-31
MY119042A (en)	2005-03-31
SI0832104T1 (en)	2003-08-31
IL122215A0 (en)	1998-04-05
AU725170B2 (en)	2000-10-05
CN1182153C (zh)	2004-12-29
DE69623472T2 (de)	2003-08-21
NZ310444A (en)	1999-11-29
AU725164B2 (en)	2000-10-05
KR19990022583A (ko)	1999-03-25
SK282466B6 (sk)	2002-02-05
NO975710D0 (no)	1997-12-05
EP0832104B1 (en)	2002-09-04
NO975710L (no)	1998-02-02
CZ376397A3 (cs)	1998-06-17
UA46775C2 (uk)	2002-06-17
MX9709146A (es)	1998-03-31
BG102152A (en)	1998-09-30
DK0832104T3 (da)	2003-01-06
KR100437986B1 (ko)	2004-09-18
HRP960277A2 (en)	1997-10-31
ZA964711B (en)	1997-12-08
AR003427A1 (es)	1998-08-05
JP3957751B2 (ja)	2007-08-15
PL323726A1 (en)	1998-04-14
KR19990022582A (ko)	1999-03-25
TR199701544T1 (xx)	1998-03-21
CZ376597A3 (cs)	1998-06-17
NO975711D0 (no)	1997-12-05
CA2219819A1 (en)	1996-12-19
HUP9801910A2 (hu)	1999-01-28
HU228071B1 (hu)	2012-09-28
CA2219818C (en)	2008-05-20
CO4700526A1 (es)	1998-12-29
NO975711L (no)	1998-01-30
HUP9801817A2 (hu)	1998-11-30
HRP960257A2 (en)	1998-02-28
MY124487A (en)	2006-06-30
DE69623992T2 (de)	2003-05-22
PL185762B1 (pl)	2003-07-31
NZ310443A (en)	1999-10-28
EP0832104A1 (en)	1998-04-01
TR199701545T1 (xx)	1998-04-21
ATE224910T1 (de)	2002-10-15
NO317670B1 (no)	2004-11-29
BR9609423A (pt)	1999-06-29
EP0871656A1 (en)	1998-10-21
TW424096B (en)	2001-03-01
UA46776C2 (uk)	2002-06-17
DE69623992D1 (de)	2002-10-31
BG102125A (en)	1998-09-30
CA2219818A1 (en)	1996-12-19
AR003136A1 (es)	1998-07-08
SK165397A3 (en)	1998-10-07
EP0871656B1 (en)	2002-09-25
CZ293683B6 (cs)	2004-07-14
AU6124196A (en)	1996-12-30
HUP9801817A3 (en)	1999-06-28
RO119783B1 (ro)	2005-03-30
BR9609424A (pt)	2000-03-28
CO4700527A1 (es)	1998-12-29
ZA964710B (en)	1997-12-08
RO118953B1 (ro)	2004-01-30
CA2219819C (en)	2008-05-20
IL122216A (en)	2002-02-10
PL323723A1 (en)	1998-04-14
SI0871656T1 (en)	2003-08-31
AU6124296A (en)	1996-12-30
TW508357B (en)	2002-11-01

Legal Events

Date	Code	Title
2002-02-10	KB	Patent renewed
2002-07-25	KB	Patent renewed
2003-09-17	HP	Change in proprietorship
2006-08-01	KB	Patent renewed
2010-11-30	KB	Patent renewed
2014-06-30	KB	Patent renewed
2016-12-29	EXP	Patent expired

Publication	Publication Date	Title
IL122215A (en)	2001-08-26	Dolastatin derivatives as antineoplastics and their preparation
IL116851A0 (en)	1996-07-23	3-arylidene-2-oxindole derivatives their preparation and use
IL118825A (en)	2000-07-16	Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
IL114795A0 (en)	1995-12-08	N-benzylindole- and benmzopyrazole derivatives their preparation and use
AP9600816A0 (en)	1996-07-31	Substituted N-indole-2-carbonyl)-B-alanimamides and derivatives as antidiabetic agents
IL119864A0 (en)	1997-03-18	1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
IL118442A0 (en)	1996-09-12	Triazolymethyl-cyclopentanols their preparation and use
IL121298A0 (en)	1998-01-04	N-(4-aryl-thiazol-2-YL)-sulphonamide derivatives and their uses
IL116139A0 (en)	1996-01-31	Pyrrole derivatives their preparation and use
IL118441A0 (en)	1996-09-12	Triazolymethyl-oxiranes their preparation and use
IL116525A0 (en)	1996-03-31	Piperazinedione derivatives their preparation and use
IL123611A0 (en)	1998-10-30	Novel amino acid derivatives their preparation and use
ZA967800B (en)	1997-04-03	Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
IL118119A0 (en)	1996-09-12	Azacycloalkane derivatives their preparation and their application in therapy
HUP9602196A2 (en)	1997-05-28	Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
HUP0003614A3 (en)	2003-04-28	Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
IL118443A0 (en)	1996-09-12	Cycloalkane-benzylidene derivatives their preparation and use
ZA943649B (en)	1995-11-27	Piperidine derivatives their preparation and use
IL123092A0 (en)	1998-09-24	Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL122686A0 (en)	1998-08-16	Benzylhydroxylamines their preparation and use
IL118444A0 (en)	1996-09-12	Mercapto-triazolyl-silanes their preparation and use
IL118629A (en)	2000-07-16	N-substituted CIS-N-propenyl-acetamides and their preparation
IL118781A0 (en)	1996-10-31	Preparation of N-protected 4-ketoproline derivatives
AU6298196A (en)	1997-01-22	Tetrahydro-betacarboline derivatives and their preparation and use
IL118547A0 (en)	1996-10-16	Aqueous film-formimg compositions and their use